✦ LIBER ✦

Sequential therapy with sorafenib and sunitinib in renal cell carcinoma

✍ Scribed by Arkadiusz Z. Dudek; Jakub Zolnierek; Anu Dham; Bruce R. Lindgren; Cezary Szczylik

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 118 KB
Volume: 115
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.24009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sorafenib in patients with metastatic re

Sorafenib in patients with metastatic renal cell carcinoma refractory to either sunitinib or bevacizumab

✍ Jorge A. Garcia; Thomas E. Hutson; Paul Elson; C. Lance Cowey; Timothy Gilligan; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB 👁 2 views

Sequential therapy in renal cell carcino

Sequential therapy in renal cell carcinoma

✍ Bernard Escudier; Marine Gross Goupil; Christophe Massard; Karim Fizazi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

Sunitinib-induced macrocytosis in patien

Sunitinib-induced macrocytosis in patients with metastatic renal cell carcinoma

✍ Brian I. Rini; Toni K. Choueiri; Paul Elson; Mohamad K. Khasawneh; Claudiu Cotta 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB 👁 1 views

Sunitinib in metastatic renal cell carci

Sunitinib in metastatic renal cell carcinoma patients with brain metastases

✍ Martin E. Gore; Subramanian Hariharan; Camillo Porta; Sergio Bracarda; Robert Ha 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB

Sunitinib rechallenge in metastatic rena

Sunitinib rechallenge in metastatic renal cell carcinoma patients

✍ Ivan N. Zama; Thomas E. Hutson; Paul Elson; James M. Cleary; Toni K. Choueiri; D 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB 👁 1 views

Prognostic nomogram for sunitinib in pat

Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma

✍ Robert J. Motzer; Ronald M. Bukowski; Robert A. Figlin; Thomas E. Hutson; M. Dro 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 3 views

## Abstract ## BACKGROUND. In a randomized, phase 3 trial, sunitinib demonstrated superior efficacy over interferon‐alfa as first‐line therapy in patients with metastatic clear‐cell renal cell carcinoma (RCC). On the basis of outcome data from that trial, the authors developed a nomogram for predi